Neil Almstead
2017
In 2017, Neil Almstead earned a total compensation of $951.9K as Executive Vice President, Research, Pharmaceutical Operations & Technology at PTC Therapeutics, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,288 |
|---|---|
| Option Awards | $270,673 |
| Salary | $434,969 |
| Stock Awards | $67,380 |
| Other | $13,608 |
| Total | $951,918 |
Almstead received $435K in salary, accounting for 46% of the total pay in 2017.
Almstead also received $165.3K in non-equity incentive plan, $270.7K in option awards, $67.4K in stock awards and $13.6K in other compensation.
Rankings
In 2017, Neil Almstead's compensation ranked 9,196th out of 14,666 executives tracked by ExecPay. In other words, Almstead earned more than 37.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,196 out of 14,666 | 37th |
Division Manufacturing | 3,536 out of 5,772 | 39th |
Major group Chemicals And Allied Products | 1,211 out of 2,075 | 42nd |
Industry group Drugs | 972 out of 1,731 | 44th |
Industry Pharmaceutical Preparations | 763 out of 1,333 | 43rd |
Source: SEC filing on April 30, 2018.
Almstead's colleagues
We found six more compensation records of executives who worked with Neil Almstead at PTC Therapeutics in 2017.
2017
Stuart Peltz
PTC Therapeutics
Chief Executive Officer
2017
Marcio Souza
PTC Therapeutics
Chief Operating Officer
2017
Mark Boulding
PTC Therapeutics
Chief Legal Officer
2017
Mark Rothera
PTC Therapeutics
Former Chief Commercial Officer
2017
Christine Utter
PTC Therapeutics
Principal Financial Officer and Treasurer
2017
Shane Kovacs
PTC Therapeutics